Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
10h
Hosted on MSNWe Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...
Tirzepatide will be available at pharmacies in Ireland initially in doses of 2.5 mg and 5 mg, with availability of higher ...
Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co. (NYSE:LLY), disclosed the sale of shares worth approximately $183.6 million, according to recent filings. The transactions, which ...
Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
Community delivery of medication of transport services, community health workers, all of these services are currently still impacted", Christine Stegling, deputy executive director of UNAIDS, told ...
It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.
While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.
Kismet, an English Springer Spaniel, and her owner Stacey Yeoman have been bringing joy to patients and staff at Novant Health Mint Hill Medical Center for the past two months as a therapy dog team.
ST. CLAIR COUNTY, Ill. – One person was left injured Wednesday morning after a vehicle was partially trapped underneath a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results